Target
ganglioside GD3
Target Alias Names
ganglioside, C68H121N3O29, (2S, 4S, 5R)-5-acetamido-6-[(1S, 2R)-2-[(2S, 4S, 5R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R, 2R)-1, 2, 3-trihydroxypropyl]oxan-2-yl]oxy-1, 3-dihydroxypropyl]-2-[(2S, 3R, 4S, 5S, 6R)-2-[(2R, 3S, 4R, 6R)-6-[(E, 2S, 3R)-2-(hexadecanoylamino)-3-hydroxyoctadec-4-enoxy]-4, 5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3, 5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxyoxane-2-carboxylic acid, CHEBI:89636, d18:1/20:0
Isotype/Mimetic
IgG3
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression